ATIG LT - Company finances
|
EUR
|
2020
From: 2020-04-11
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|
|
Financial data
|
||||||
| Sales revenue | 0 | 0 | 1,509,294 | 2,501,180 | 3,674,248 | 5,863,534 |
| Profit before tax | 0 | 0 | 279,331 | 311,756 | 481,721 | 726,378 |
| Net profit | 0 | 0 | 237,431 | 311,756 | 304,894 | 592,012 |
| Equity | 2,500 | 2,500 | 239,931 | 579,187 | 831,123 | 1,307,140 |
| Liabilities | 0 | 0 | 287,969 | 61,493 | 330,893 | 1,208,826 |
| Non-current assets | 0 | 0 | 2,969 | 200,213 | 177,161 | 322,538 |
| Current assets | 2,500 | 2,500 | 524,931 | 440,467 | 984,855 | 2,193,428 |
| Total assets | 2,500 | 2,500 | 527,900 | 640,680 | 1,162,016 | 2,515,966 |
|
Taxes paid
|
||||||
| STI taxes | - | - | - | 71,545 | 88,572 | 416,265 |
| Social insurance contributions | - | - | - | - | 4,189 | 33,851 |
|
Financial indicators
|
||||||
| Revenue change y/y | - | - | - | +65.7% | +46.9% | +59.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.0% | 0.0% | 45.0% | 48.7% | 26.2% | 23.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.0% | 0.0% | 99.0% | 53.8% | 36.7% | 45.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | 15.7% | 12.5% | 8.3% | 10.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | 18.5% | 12.5% | 13.1% | 12.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | 1.2 | 0.1 | 0.4 | 0.9 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | 754,647 | 1,250,590 | 1,574,700 | 1,116,864 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
ATIG LT - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-10-16 | 2025-11-02 | 110.34 |
| 2025-07-26 | 2025-07-31 | 110.36 |
| 2025-07-16 | 2025-07-20 | 110.36 |
| 2025-02-18 | 2025-02-18 | 2476.95 |
| 2025-01-22 | 2025-02-13 | 47.09 |
| 2025-01-16 | 2025-01-21 | 44.85 |
| 2025-01-02 | 2025-01-14 | 46.48 |
| 2024-12-22 | 2024-12-31 | 46.48 |
| 2024-12-17 | 2024-12-20 | 46.48 |
| 2024-11-19 | 2024-12-08 | 1.63 |
| 2024-11-18 | 2024-11-18 | 1831.37 |
| 2024-10-24 | 2024-11-17 | 1.63 |
| 2024-10-16 | 2024-10-17 | 1407.66 |
| 2024-09-17 | 2024-09-17 | 1407.66 |
| 2024-08-19 | 2024-08-19 | 1407.66 |
| 2023-11-16 | 2023-12-17 | 1.53 |
| 2023-10-25 | 2023-11-12 | 1.53 |
| 2023-10-17 | 2023-10-24 | 0.70 |
| 2023-09-18 | 2023-10-10 | 0.70 |
| 2023-08-17 | 2023-09-17 | 0.71 |
| 2023-07-28 | 2023-08-15 | 0.72 |
| 2023-07-24 | 2023-07-25 | 0.75 |
| 2023-06-16 | 2023-06-18 | 842.06 |
| 2023-05-02 | 2023-05-15 | 0.34 |
| 2023-04-26 | 2023-04-28 | 0.34 |
| 2023-02-06 | 2023-02-14 | 0.69 |
| 2023-01-24 | 2023-02-03 | 0.69 |
| 2023-01-23 | 2023-01-23 | 0.49 |
| 2023-01-20 | 2023-01-22 | 0.69 |
| 2022-12-16 | 2023-01-19 | 0.49 |
| 2022-11-21 | 2022-12-14 | 0.49 |
| 2022-10-28 | 2022-11-18 | 0.49 |
| 2022-07-25 | 2022-08-22 | 0.21 |
ATIG LT - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-07-17 | 2025-07-20 | 12152.17 |
| 2025-07-09 | 2025-07-16 | 12137.16 |
| 2025-06-19 | 2025-06-19 | 98.31 |
| 2025-06-01 | 2025-06-12 | 0.14 |
| 2025-05-30 | 2025-05-31 | 1.39 |
| 2025-05-03 | 2025-05-29 | 0.14 |
| 2025-05-01 | 2025-05-02 | 0.7 |
| 2025-03-29 | 2025-04-30 | 0.14 |
| 2025-03-24 | 2025-03-24 | 4061.62 |
| 2025-03-22 | 2025-03-23 | 3848.21 |
| 2025-02-15 | 2025-02-17 | 850.57 |
| 2024-11-17 | 2024-11-23 | 1025.81 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
ATIG LT, UAB (code 305534783) is a Private Limited Liability Company operating in wholesale of pharmaceutical and medical goods. In 2025, the company generated EUR 5.86 million in revenue, up 59.6% year on year and 134.4% compared with 2023. Net profit increased to EUR 592.0 thousand in 2025, after EUR 304.9 thousand in 2024 and EUR 311.8 thousand in 2023, showing a clear improvement in profitability. The 2025 net profit margin stood at 10.1%, compared with 8.3% in 2024 and 12.5% in 2023. Balance sheet size expanded significantly, with total assets rising to EUR 2.52 million in 2025 from EUR 1.16 million in 2024 and EUR 640.7 thousand in 2023. Equity reached EUR 1.31 million, while liabilities increased to EUR 1.21 million. The equity ratio was 52.0% and debt-to-equity was 0.92, indicating a more leveraged but still balanced capital structure. Asset turnover was 2.33x. Revenue per employee was EUR 1.17 million and profit per employee EUR 118.4 thousand.